Optimizing Multiple Sclerosis Management

Optimizing Multiple Sclerosis Management
1 ANCC Contact Hours 1 AMA PRA Category 1 Credit(s)
Launch Date:
September 24, 2015
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Neurologists, primary care physicians, nurse clinicians, nurse practitioners, and physician assistants with an interest in the management of MS

Relevant Terms:

Multiple sclerosis

Scott Newsome, DO

Scott Newsome, DO
Assistant Professor of Neurology
Director, Neurology Outpatient Services
Director, Neurology Infusion Center
Johns Hopkins Neuroimmunology and Neuroinfectious Diseases
Johns Hopkins Hospital
Baltimore, MD

Scott Newsome, DO, is Director of The Johns Hopkins Neurology Outpatient Services and the Neurology Infusion Center, and Assistant Professor of Neurology, at The Johns Hopkins University. Dr Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He has special interest in evaluating and treating patients with multiple sclerosis (MS), transverse myelitis, neuromyelitis optica, and stiff person syndrome. Dr Newsome received his medical degree from the New York College of Osteopathic Medicine, graduating with honors. He then completed his internship in internal medicine and residency in neurology at Albany Medical Center. During Dr Newsome's neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award and later was chosen to be Chief Resident. He went on to complete a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship from the National Multiple Sclerosis Society. Dr Newsome joined The Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers after completing his fellowship. Dr Newsome's main research focuses on the use of new quantitative clinical outcome measures and imaging techniques in MS. These tools may improve the precision of disability measurements in MS and other central nervous system disorders. Currently, Dr Newsome is involved in several clinical trials for MS, transverse myelitis, and neuromyelitis optica. He also serves as Chair for the Consensus Conference Committee of the Consortium of MS Centers and is an advisor for the National Multiple Sclerosis Society Clinical Advisory Committee.

June Halper, MSN, APN-C, MSCN, FAAN

June Halper, MSN, APN-C, MSCN, FAAN
Chief Executive Officer, CMSC
Executive Director, IOMSN
Executive Director, MSNICB
Hackensack, NJ

June Halper, MSN, APN-C, MSCN, FAAN, is a Certified Adult Nurse Practitioner specializing in multiple sclerosis (MS) since 1978. She was a founder of the Gimbel MS Center in Teaneck, New Jersey, and was the Executive Director from 1989-2008. With the Multiple Sclerosis Research and Treatment Center of the New Jersey Medical School, UMDNJ, the Gimbel Center established the Multiple Sclerosis Network of New Jersey in 1998. In 1993, the Gimbel MS Center was named the administrative seat of the Consortium of Multiple Sclerosis Centers (CMSC), the largest organization of MS healthcare professionals in the world. Ms Halper was President of the CMSC from 1995-1997 and has been the Executive Director since 1997.
Ms Halper spearheaded the development of a national task force on disabled women's health issues, culminating in a nationally attended conference in June 1996, which focused on autoimmune diseases and women. She has published and lectured extensively on MS and its ramifications, and is the editor of Comprehensive Nursing Care in Multiple Sclerosis and Advanced Concepts in Nursing Care in Multiple Sclerosis, co-editor of Staying Well With Multiple Sclerosis: A Self-Care Guide, and co-editor of Nursing Practices in Multiple Sclerosis: A Core Curriculum. Ms Halper chaired the first Multiple Sclerosis Nurse Specialist Consensus Committee's development of a monograph on the nurse's role in adherence to complex protocols; the impact of cognitive impairment in MS nursing care; and the nurse's role in the patient's and family's quality of life. She also chaired the second such committee which published Multiple Sclerosis: Best Practices in Nursing Care: Disease Management, Pharmacologic Treatment, Nursing Research. Ms Halper is a member of the American Academy of Nurse Practitioners, the founding director of the International Organization of MS Nurses (IOMSN), and the recipient of the IOMSN's first June Halper Award for Excellence in Nursing in Multiple Sclerosis. She was inducted as a Fellow into the American Academy of Nursing in November 1999. In 2000, she spearheaded the establishment of the Multiple Sclerosis International Credentialing Board, which developed the first international certification examination in MS nursing, first offered in June 2002 and biannually thereafter. As Executive Director of the CMSC, Ms Halper initiated the first certification examination for multi-disciplinary MS specialists in 2004. In 2010, she oversaw CMSC's approval by the Accreditation Council for Continuing Medical Education (ACCME) as a provider of continuing medical education for physicians.
1. Implement strategies for the early assessment of MS and monitoring of disease progression 
2. Recognize the differences in MS clinical presentation and treatment responses among patients of different racial backgrounds 
3. Evaluate current and emerging therapies in the management of MS and their risks and benefits
4. Utilize educational and communication strategies to explain therapeutic goals and treatment options and address patient adherence

Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Consortium of Multiple Sclerosis Centers (CMSC) and Spire Learning. CMSC is accredited by the ACCME to provide continuing medical education for physicians.
CMSC designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
Nurses: This activity is offered through the joint providership of Nurse Practitioner Alternatives (NPA), CMSC, and Spire Learning. NPA is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
NPA designates this enduring activity for a maximum of 1.0 contact hours of continuing education for nurses and nurse practitioners.
According to the disclosure policies of CMSC and NPA, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence.
Scott Newsome, DO 
Advisory Board/Consultant: Biogen Idec; Genzyme, a Sanofi Company
Research: Principal Investigator for clinical trials: Biogen Idec and Novartis Pharmaceuticals Corporation, and funds are paid to his institution  
June Halper, MSN, APN-C, MSCN, FAAN
Consultant (research activity): Biogen Idec  
Independent Reviewer
Corey Ford, MD, PhD, serves as the Chair of the Continuing Professional Education Committee at The Consortium of Multiple Sclerosis Centers (CMSC) and discloses the following relationships:
Consulting Agreements: Biogen Idec; Novartis Pharmaceuticals Corporation; Teva Pharmaceuticals
Sources of Funding for Research: Biogen Idec; Elan; EMD Serono, Inc; Genentech, a member of the Roche Group; Genzyme, a Sanofi Company; Janssen Pharmaceuticals, Inc; Novartis Pharmaceuticals Corporation; Ono Pharmaceutical Co, Ltd; Sanofi US; Teva Pharmaceuticals
Nurse Planner
Nurse Practitioner Alternatives (NPA)
Laurie Scudder, DNP, NP, has served as nurse planner for this activity and has disclosed no relevant financial relationships.
Educational Planning Committee
The Consortium of Multiple Sclerosis Centers (CMSC)
June Halper, MSN, APN-C, MSCN, FAAN, is a consultant to Biogen Idec for a research activity.
Spire Learning
Christine Kocienda
Shareholder (spouse/partner): Johnson & Johnson; Procter & Gamble
Kashemi Rorie, PhD
Nothing to disclose with regard to commercial support

The opinions expressed in this educational activity are those of the faculty, and do not represent those of the CMSC, NPA, or Spire Learning. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should critically appraise the information presented and draw conclusions only after careful consideration of all available scientific information.
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Levels of Evidence
Levels of evidence are provided for any patient care recommendations made during this presentation.
Level A (randomized controlled trial/meta-analysis): High-quality, randomized controlled trial (RCT) that considers all important outcomes. High-quality meta-analysis (quantitative systematic review) using comprehensive search strategies.
Level B (other evidence): A well-designed, nonrandomized clinical trial. A nonquantitative systematic review with appropriate search strategies and well-substantiated conclusions. Includes lower-quality RCTs, clinical cohort studies and case-controlled studies with nonbiased selection of study participants and consistent findings. Other evidence, such as high-quality, historical, uncontrolled studies, or well-designed epidemiologic studies with compelling findings, is also included.
Level C (consensus/expert opinion): Consensus viewpoint or expert opinion

Each rating is applied to a single reference in the presentation, not the entire body of evidence on the topic.

Sponsorship Statement: This educational activity is jointly provided by the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), and Spire Learning.
Support Statement: This activity is supported by independent, unrestricted educational grants from Acorda Therapeutics, Inc; Allergan, Inc; Biogen Idec; and Teva Pharmaceuticals.

Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8                  
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash or Quicktime.